Standout Papers
- Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer (2019)
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease (2012)
- Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1 (2020)
Immediate Impact
1 by Nobel laureates 13 from Science/Nature 58 standout
Citing Papers
A vision–language foundation model for precision oncology
2025 StandoutNature
Alkene dialkylation by triple radical sorting
2024 StandoutNature
Works of David Mills being referenced
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David Mills | 1174 | 1544 | 1570 | 1586 | 25 | 4.1k | |
| Francesca Carlomagno | 878 | 2892 | 2360 | 2456 | 89 | 6.1k | |
| Jean M. Whaley | 517 | 1886 | 560 | 1611 | 32 | 3.6k | |
| Francesco Hofmann | 891 | 4152 | 1433 | 871 | 55 | 5.8k | |
| Houtan Noushmehr | 1106 | 3688 | 1123 | 508 | 48 | 5.4k | |
| Todd Juan | 1114 | 1681 | 2994 | 519 | 47 | 5.6k | |
| David T. Hung | 2269 | 2172 | 747 | 642 | 24 | 7.0k | |
| Marco M. Gottardis | 869 | 3355 | 1736 | 1458 | 134 | 6.4k | |
| Frank Himmelsbach | 1305 | 1586 | 1628 | 864 | 30 | 3.3k | |
| Stewart Fleming | 2111 | 4143 | 642 | 1003 | 81 | 6.2k | |
| Robert L. Wolfert | 1329 | 1673 | 521 | 408 | 55 | 4.5k |
All Works
Loading papers...